Pfizer (PFE) Tops Q3 EPS by 29c, Raises FY Guidance

Pfizer (NYSE: PFE) reported Q3 EPS of $1.37, $0.29 better than the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.

GUIDANCE:

Pfizer sees 2021 EPS of $4.13-$4.18 (previously $3.95 to $4.05). Pfizer sees 2021 revenue of $81-82 billion (previously $78.0 to $80.0 billion).

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance